Gait characteristics in people with Friedreich ataxia: daily life versus clinic measures. [PDF]
Casey HL +10 more
europepmc +1 more source
Managing Aminotransferase Elevations in Patients with Friedreich Ataxia Treated with Omaveloxolone: A Review and Expert Opinion on Use Considerations. [PDF]
Perlman S +4 more
europepmc +1 more source
Friedreich ataxia: what can we learn from non-GAA repeat mutations? [PDF]
Lynch DR, Shen M, Wilson RB.
europepmc +1 more source
Inhibition of Rho-Associated Kinases ROCK1 and ROCK2 as a Therapeutic Strategy to Reactivate the Repressed <i>FXN</i> Gene in Friedreich Ataxia. [PDF]
Fang M +8 more
europepmc +1 more source
Predictive machine learning and multimodal data to develop highly sensitive, composite biomarkers of disease progression in Friedreich ataxia. [PDF]
Saha S +4 more
europepmc +1 more source
Uniparental IsoDisomy: a case study on a new mechanism of Friedreich ataxia. [PDF]
Sperelakis-Beedham B +12 more
europepmc +1 more source
New and Emerging Drug and Gene Therapies for Friedreich Ataxia. [PDF]
Scott V, Delatycki MB, Tai G, Corben LA.
europepmc +1 more source
Longitudinal analysis of anthropometric measures over 5 years in patients with Friedreich ataxia in the EFACTS natural history study. [PDF]
Lischewski SA +26 more
europepmc +1 more source
Gradient of microstructural damage along the dentato-thalamo-cortical tract in Friedreich ataxia. [PDF]
Cocozza S +16 more
europepmc +1 more source

